FY2024 · ended Sep 30, 2024 · Revenue $16.89M, +3.6% YoY · Filed Dec 17, 2025
Veru Inc. (VERU) files with the SEC under industry code 2834, Pharmaceutical Preparations. Free cash flow was -$30.0 million. As of Jun 30, 2026 it held $23.9 million in cash and investments and $2.7 million in total debt.
Revenue
$16.89M
+3.6% vs prior year
Net income
$-22.73M
+39.9% vs prior year
Operating cash flow (TTM)
$-26.04M
+9.9% vs year-ago TTM
Free cash flow (TTM)
$-26.04M
+10.1% vs year-ago TTM
EPS
$-1.10
-4.8% vs prior year
Dividend per share
$0.26
Shares outstanding
16.05M
-89.0% vs prior year
Net cash
$21.20M
as of Jun 30, 2026
Operating margin
-214.2%
FY 2024
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VERU (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- WI
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 863894
- Former names
- FEMALE HEALTH CO (until Aug 1, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Sep 30, 2025 |
FY 2024 Sep 30, 2024 |
FY 2023 Sep 30, 2023 |
FY 2022 Sep 30, 2022 |
FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| Revenue | — | $16.9M | $16.3M | $39.4M | $61.3M |
| Operating income | -$24.8M | -$36.2M | -$93.8M | -$83.5M | $13.0M |
| Net income | -$22.7M | -$37.8M | -$93.2M | -$84.0M | $7.4M |
| Diluted EPS | — | — | -$1.10 | -$1.05 | $0.09 |
| Operating cash flow | -$30.0M | -$21.7M | -$88.0M | -$47.5M | -$15.6M |
| Free cash flow | -$30.0M | -$21.8M | -$88.7M | -$48.2M | -$15.9M |
| Total assets | $29.8M | $60.4M | $50.0M | $135.4M | $178.1M |
| Total liabilities | $11.5M | $28.1M | $30.3M | $52.6M | $25.9M |
| Stockholders' equity | $18.3M | $32.3M | $19.7M | $82.8M | $154.5M |
| Cash and investments | $15.8M | $24.9M | — | — | — |
| Total debt | $3.1M | $4.0M | $4.7M | $5.1M | $1.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 8, 2026 | Sep 8, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 2, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Other events
|
Jun 4, 2026 | Jun 2, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
All 1000 Veru Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.